ArticleEuropean urology2022

Re: Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study.

Elisabeth Grobet-Jeandin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.